Goodwin has been named a U.S. Life Cycle firm by LMG Life Sciences for the ninth consecutive year. This distinction recognizes Goodwin for being ranked in all of the practice areas covered by LMG Life Sciences, reinforcing the firm’s reputation for robust practice offerings and ability to partner with clients in order to meet their needs throughout the entire corporate life-cycle.
Twenty-three Goodwin partners were named LMG Life Sciences Stars, which honors the top practitioners in their fields. Goodwin was also highly ranked in nine practice areas.
LMG referred to Goodwin as a “powerhouse in IP and transactions” while also noting the firm possessed “high technical competence” and “excellent litigation and trial skills.”
The following Goodwin practice areas were recognized for excellence:
- General Corporate – Highly Recommended
- General Patent Litigation – Highly Recommended
- Hatch-Waxman Patent Litigation (Generic) – Highly Recommended
- Licensing & Collaboration – Highly Recommended
- Mergers & Acquisitions – Highly Recommended
- Patent Strategy and Management – Highly Recommended
- Venture Capital – Highly Recommended
- Product Liability & Recall – Recommended
- White – Collar/Government Investigations – Recommended
The following Goodwin lawyers were honored as Life Sciences Stars:
- Deborah Birnbach (White-Collar/Government Investigations)
- Michael Bison (Licensing & Collaboration, Mergers & Acquisitions, Venture Capital)
- Elaine Blais (General Patent Litigation)
- Mitchell Bloom (Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital)
- Kristopher Brown (Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital)
- Stuart Cable (Corporate, Mergers & Acquisitions)
- Marta Delsignore (Patent Strategy & Management)
- Anthony Downs (General Patent Litigation, Hatch-Waxman Patent Litigation)
- Joanne Gray (Product Liability)
- Duncan Greenhalgh (Patent Prosecution, Patent Strategy & Management)
- William Harrington (White Collar/Government Investigations)
- David Hashmall (Hatch-Waxman Patent Litigation)
- Theresa Kavanaugh (Patent Prosecution, Patent Strategy & Management)
- Douglas Kline (General Patent Litigation)
- Michael Shuster (Patent Prosecution, Patent Strategy & Management)
- Sarah Solomon (Licensing & Collaboration, Mergers & Acquisitions)
- Kingsley Taft (Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital)
- Julie Tibbets (FDA: Pharmaceutical, FDA: Medical Device)
- Daryl Wiesen (General Patent Litigation, Hatch-Waxman Patent Litigation)
- Maggie Wong (Corporate, Licensing & Collaboration, Mergers & Acquisitions, Venture Capital)
LMG Life Sciences research involved over 1,000 surveys and interviews with nearly 600 leading attorneys in the United States, as well as a review of public information and feedback from clients within the industry.